Taiwan FDA registration 1aefed4d03396947513cffe3f2da9fec
"Bolix" new Libo breast implants
TW: “波力媚”新力波乳房植入物
Taiwan·Risk Class 3·ESTABLISHMENT LABS S.A.·Registered Jan 14, 2019 – Jan 14, 2029ActiveRegistration details
- Analysis ID
- 1aefed4d03396947513cffe3f2da9fec
- Customs Code
- DHA05603194304
Company information
- Manufacturer
- ESTABLISHMENT LABS S.A.
- Manufacturer Country
- Costa Rica
- Authorized Representative
- WOH MEDICAL CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.3540 Silicone-filled breast supplements
- Import Information
- Import;; Safety monitoring
Dates and status
- Registration Date
- Jan 14, 2019
- Expiry Date
- Jan 14, 2029
About this record
Access comprehensive regulatory information for "Bolix" new Libo breast implants in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 1aefed4d03396947513cffe3f2da9fec and manufactured by ESTABLISHMENT LABS S.A.. The authorized representative in Taiwan is WOH MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices